Target therapy drugs make use of inhibitors to attempt to help people suffering from Melanoma to live longer, as well as to have a higher quality of life during the treatment process. These drugs and medications include: dabrafenib (Tafinlar), vemurafenib (Zelboraf), trametinib (Mekinist) and cobimetinib (Cotellic). In over half of the cases of melanoma, changes in the BRAF genes may occur. When this happens, these patients typically respond the best to targeted therapy, offering them a real chance to slow down the other effects of this sometimes lethal type of skin cancer.

This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.